<!doctype html>
<html lang="en">
<head>
    <meta charset="utf-8"/>
    <meta name="viewport" content="width=device-width, initial-scale=1"/>
    <title>Program Details - GENOME PROGRAM (PKGenP)</title>
    <meta
            name="description"
            content="Detailed information about the Pakistan Genome Program (PKGenP)."
    />
    <link rel="stylesheet" href="assets/styles.css"/>
</head>
<body>
<header>
    <div class="container nav">
        <div class="logo">
            <img src="assets/images/precision-omics-icon.png" alt="Precision Omics Logo" class="logo-img"/>
        </div>
        <nav><a href="index.html">Home</a><a href="program.html" aria-current="page">Program Details</a><a href="index.html#team">Team</a><a href="index.html#news">News</a><a
                href="index.html#contact">Contact</a></nav>
    </div>
</header>
<section class="container hero-grid hero">
    <div class="reveal">

        <span class="pill">NATIONAL INITIATIVE</span>
        <span class="pill">VISION 2030</span>
        <h1>PAKISTAN</h1>
        <h2>GENOME PROGRAM (PKGenP)</h2>
        <div class="hero-info">
            <h3>A Globally Recognized National Asset for Pakistan</h3>
            <span>Establishing a Library of Sequenced Genomes. A strategy for the future of Pakistan‚Äôs Health Care and
                    Industrial Infrastructure</span>
            <div class="tag">OUR VISION</div>
            A healthier Pakistan powered by <span class="highlight">genomics</span>, delivering <span
                class="highlight">equitable, data-driven precision healthcare</span> for every citizen.
            <div class="tag">OUR MISSION</div>
            <ul>
                <li><span class="highlight">Genetic Profiling</span> of local Population</li>
                <li><span class="highlight">Early Detection</span> of Cancer</li>
                <li><span class="highlight">Improve</span> Patients Health</li>
                <li><span class="highlight">Increase</span> the Survival Rate</li>
                <li><span class="highlight">Reduce</span> Treatment Cost</li>
                <li><span class="highlight">Local Manufacturing</span> of Medicine</li>
            </ul>
            <div class="tag">Benefits for Pakistan</div>
            <ul>
                <li>Set Pakistan up to become a future <span class="highlight">Regional Powerhouse</span> for Drug
                    discovery
                </li>
                <li>Improve on <span class="highlight">National Health Priorities</span> (especially Cancer
                    Targets)
                </li>
                <li>Building leading edge <span class="highlight">High Tech Genomics AI based Infrastructure</span>
                </li>
                <li>Create and Develop <span class="highlight">high skill jobs</span> and attract <span
                        class="highlight">Global Investments</span></li>
                <li>Make a <span class="highlight">Global Center for Research & Clinical Trials</span> by
                    strengthening of domestic scientific and Clinical Capabilities
                </li>
            </ul>
        </div>
    </div>
    <div class="card reveal">
        <h3>Program Overview</h3>
        <p>A transformative national initiative to establish a genomics ecosystem that improves disease prevention,
            diagnosis, and treatment equity across Pakistan along with establishment of independent Governance &
            Ethics Board comprising of internationally recognized life Science leader for oversight.</p>
        <div class="program-projects">
            <div class="project-item">
                <span class="project-icon">üß¨</span>
                <h4>Cancer Genome Project</h4>
            </div>
            <div class="project-item">
                <span class="project-icon">üéØ</span>
                <h4>Priorities other unmet need Projects</h4>
            </div>
            <div class="project-item">
                <span class="project-icon">üåç</span>
                <h4>Large Scale Global Access Eurasian Research Library Project</h4>
            </div>
            <div class="project-item">
                <span class="project-icon">üíä</span>
                <h4>Drug Discovery Enterprise Project</h4>
            </div>
            <div class="project-item">
                <span class="project-icon">ü§ù</span>
                <h4>Pharma and Biotech Engagement Project</h4>
            </div>
        </div>
    </div>
</section>
<section id="cancer-burden">
    <div class="container">
        <div class="section-title reveal"><h2>Cancer Burden in Pakistan</h2>
            <p>Annual Report Data Updated 2025-2026</p></div>
        <div class="stats-grid">
            <div class="stat-card reveal">
                <div class="stat-number">185,748</div>
                <div class="stat-label">NEW CASES (ANNUALLY)</div>
            </div>
            <div class="stat-card reveal">
                <div class="stat-number">125,000+</div>
                <div class="stat-label">ANNUAL MORTALITY</div>
            </div>
            <div class="stat-card reveal">
                <div class="stat-number">105.6 / 100k</div>
                <div class="stat-label">INCIDENCE RATE</div>
            </div>
            <div class="stat-card reveal">
                <div class="stat-number">69.8 / 100k</div>
                <div class="stat-label">MORTALITY RATE</div>
            </div>
        </div>
        <div class="burden-analysis">
            <div class="card reveal">
                <h4>Key Challenges</h4>
                <ul>
                    <li><span class="highlight">High case fatality ratio</span></li>
                    <li><span class="highlight">Rising Trend</span></li>
                    <li><span class="highlight">500,000+</span> Existing Prevalence (Active Cases)</li>
                    <li><span class="highlight">75%+</span> LATE STAGE (III/IV) - Major barrier to curative treatment</li>
                </ul>
            </div>
            <div class="card reveal">
                <h4>Diagnostic Stage Distribution</h4>
                <p>Percentage of patients diagnosed at advanced stages</p>
                <p>Comparative rates per 100,000 population</p>
                <p><em>Sources: IARC GLOBOCAN 2024</em></p>
            </div>
        </div>
    </div>
</section>
<section id="why-patients-suffer" class="hero">
    <div class="container">
        <div class="section-title reveal"><h2>Why Cancer Patients Suffer in Pakistan</h2>
            <p>Local Healthcare Limitations</p></div>
        <div class="card reveal">
            <h3>Diagnostic Challenges in Pakistan</h3>
            <div class="stats-grid">
                <div class="stat-card reveal">
                    <div class="stat-number">70%</div>
                    <div class="stat-label">LATE STAGE DIAGNOSIS</div>
                </div>
                <div class="stat-card reveal">
                    <div class="stat-number">75%+</div>
                    <div class="stat-label">STAGE III/IV</div>
                </div>
            </div>
            <div class="challenge-analysis">
                <div class="challenge-card reveal">
                    <h4>Late-Stage Diagnosis</h4>
                    <p>Due to lack of screening and awareness, 60-70% of cancer patients are diagnosed at Stage III or IV, drastically reducing survival rates.</p>
                </div>
                <div class="challenge-card reveal">
                    <h4>Major Drop-off</h4>
                    <p>Only a fraction of patients get precision care due to limited infrastructure and expertise.</p>
                </div>
            </div>
        </div>
    </div>
</section>
<section id="current-treatment">
    <div class="container">
        <div class="section-title reveal"><h2>Current Treatment Landscape</h2>
            <p>Public Sector Focus - PAEC & Tertiary Care</p></div>
        <div class="treatment-overview">
            <div class="card reveal">
                <h3>INFRASTRUCTURE, MODALITIES & CAPABILITIES</h3>
                <div class="stats-grid">
                    <div class="stat-card reveal">
                        <div class="stat-number">40,000+</div>
                        <div class="stat-label">NEW PATIENTS / YEAR</div>
                    </div>
                    <div class="stat-card reveal">
                        <div class="stat-number">19+</div>
                        <div class="stat-label">CANCER HOSPITALS</div>
                    </div>
                </div>
                <div class="treatment-details">
                    <h4>National Backbone</h4>
                    <p>Pakistan Atomic Energy Commission (PAEC) manages the majority of cancer treatment facilities with subsidized care and nuclear medicine focus.</p>
                    <h4>Available Modalities</h4>
                    <ul>
                        <li>Surgery</li>
                        <li>Chemotherapy</li>
                        <li>Radiotherapy</li>
                        <li>Limited Precision Medicine</li>
                    </ul>
                </div>
            </div>
        </div>
        <div class="limitations-grid">
            <div class="limitation-card reveal">
                <h4>SHORTAGE</h4>
                <p>Only 21.4% of patients can access radiotherapy facilities despite over 60% requiring it, creating massive backlogs and treatment delays.</p>
            </div>
            <div class="limitation-card reveal">
                <h4>Precision Constraints</h4>
                <p>Limited access to molecular diagnostics and targeted therapies, resulting in suboptimal treatment outcomes.</p>
            </div>
        </div>
    </div>
</section>
<section id="precision-medicine" class="hero">
    <div class="container">
        <div class="section-title reveal"><h2>What Is Precision Medicine?</h2>
            <p>Strategic Concept - Molecular Oncology</p></div>
        <div class="paradigm-shift">
            <div class="approach-card reveal">
                <h4>Traditional Approach</h4>
                <div class="approach-visual">
                    <div class="drug-box">Drug A</div>
                    <div class="patients-group">
                        <div class="patient responder">Responders</div>
                        <div class="patient non-responder">Non-Responders</div>
                        <div class="patient toxic">Toxic Effects</div>
                    </div>
                </div>
                <p class="approach-desc">"ONE SIZE FITS ALL" - Treatment is based on the organ of origin (e.g., Lung Cancer), regardless of underlying biology.</p>
            </div>
            <div class="approach-card reveal">
                <h4>Precision Medicine</h4>
                <div class="approach-visual">
                    <div class="biomarker-groups">
                        <div class="biomarker-group">
                            <div class="drug-box">Drug B</div>
                            <div class="patient-group">Patients Grouped by Biomarkers</div>
                        </div>
                        <div class="biomarker-group">
                            <div class="drug-box">Drug C</div>
                        </div>
                    </div>
                </div>
                <p class="approach-desc">"Treatment targets the specific molecular driver (e.g., EGFR mutation), maximizing efficacy."</p>
            </div>
        </div>
        <div class="workflow-section">
            <div class="card reveal">
                <h4>WORKFLOW THE PRECISION OMICS CYCLE</h4>
                <div class="workflow-steps">
                    <div class="step">
                        <div class="step-number">1</div>
                        <div class="step-text">Biopsy<br><small>Sample Collection</small></div>
                    </div>
                    <div class="step">
                        <div class="step-number">2</div>
                        <div class="step-text">WGS / Omics<br><small>Genomic Profiling</small></div>
                    </div>
                    <div class="step">
                        <div class="step-number">3</div>
                        <div class="step-text">Bioinformatics<br><small>Data Analysis</small></div>
                    </div>
                    <div class="step">
                        <div class="step-number">4</div>
                        <div class="step-text">Tumor Board<br><small>Expert Review</small></div>
                    </div>
                    <div class="step">
                        <div class="step-number">5</div>
                        <div class="step-text">Intervention<br><small>Targeted Therapy / Trial</small></div>
                    </div>
                    <div class="step">
                        <div class="step-number">6</div>
                        <div class="step-text">Outcomes<br><small>Tracking & Adjustment</small></div>
                    </div>
                </div>
                <p class="strategic-goal"><strong>Strategic Goal:</strong> Integrate this workflow into Pakistan's national cancer care network.</p>
            </div>
        </div>
    </div>
</section>
<section id="global-revolution">
    <div class="container">
        <div class="section-title reveal"><h2>Global Precision Medicine Revolution</h2>
            <p>From Reactive to Proactive Healthcare</p></div>
        <div class="card reveal">
            <h3>Paradigm Shift</h3>
            <p>Moving away from "one-size-fits-all" medicine to a proactive, data-driven approach where prevention and early detection take precedence over late-stage reaction.</p>
            <div class="workflow-visual">
                <div class="workflow-step">
                    <span class="step-number">1</span>
                    <h4>Sequence</h4>
                    <p>Genomic analysis</p>
                </div>
                <div class="workflow-step">
                    <span class="step-number">2</span>
                    <h4>Analyze</h4>
                    <p>Bioinformatics</p>
                </div>
                <div class="workflow-step">
                    <span class="step-number">3</span>
                    <h4>Diagnose</h4>
                    <p>Molecular profiling</p>
                </div>
                <div class="workflow-step">
                    <span class="step-number">4</span>
                    <h4>Treat</h4>
                    <p>Precision therapy</p>
                </div>
                <div class="workflow-step">
                    <span class="step-number">5</span>
                    <h4>Monitor</h4>
                    <p>Track response</p>
                </div>
            </div>
        </div>
    </div>
</section>
<section id="success-stories" class="hero">
    <div class="container">
        <div class="section-title reveal"><h2>Global Success Stories</h2>
            <p>International Case Studies & Lessons Learned</p></div>
        <div class="success-stories-grid">
            <div class="success-card reveal">
                <h3>The UK 100,000 Genomes Project</h3>
                <div class="success-stats">
                    <div class="success-stat">
                        <span class="stat-number">100,000</span>
                        <span class="stat-label">Genomes Sequenced</span>
                    </div>
                </div>
                <p>Established by Genomics England, this landmark initiative sequenced 100,000 whole genomes from NHS patients with rare diseases and common cancers. It successfully integrated genomic medicine into routine healthcare.</p>
                <div class="case-study">
                    <h4>Case Study: Rare Disease Impact</h4>
                    <p>THE CHALLENGE: Patients with undiagnosed rare diseases spent years navigating diagnostic odysseys.</p>
                    <p>THE RESULT: 25% of previously undiagnosed patients received definitive diagnoses through WGS.</p>
                </div>
            </div>
        </div>
    </div>
</section>
<section id="national-programs">
    <div class="container">
        <div class="section-title reveal"><h2>Other National Genome Programs</h2>
            <p>Global Initiatives & Lessons Learned</p></div>
        <div class="programs-grid">
            <div class="program-card reveal">
                <h3>China: Precision Medicine Initiative</h3>
                <div class="program-stats">
                    <div class="program-stat">
                        <span class="stat-number">$9B</span>
                        <span class="stat-label">Investment</span>
                    </div>
                </div>
                <p>A massive $9B investment focusing on large-scale cohort studies and oncology. It integrates big data with clinical care to accelerate pharmaceutical innovation.</p>
            </div>
            <div class="program-card reveal">
                <h3>UAE: National Genome Program</h3>
                <div class="program-stats">
                    <div class="program-stat">
                        <span class="stat-number">Regional</span>
                        <span class="stat-label">Leader</span>
                    </div>
                </div>
                <p>Establishing comprehensive genomic infrastructure to become a regional leader in precision medicine and genomics research.</p>
            </div>
        </div>
    </div>
</section>
<section id="wgs-role" class="hero">
    <div class="container">
        <div class="section-title reveal"><h2>Role of Whole Genome Sequencing (WGS)</h2>
            <p>Technology Overview - 100% Genomic Coverage</p></div>
        <div class="card reveal">
            <h3>THE GOLD STANDARD FOR COMPREHENSIVE GENOMIC PROFILING</h3>
            <div class="wgs-comparison">
                <div class="wgs-item">
                    <div class="wgs-coverage">
                        <span class="coverage-percent">100%</span>
                        <span class="coverage-label">of the Genome</span>
                    </div>
                    <div class="wgs-details">
                        <h4>Whole Genome Sequencing</h4>
                        <p>~3 Billion bp</p>
                        <p><strong>150,000+</strong> Actionable Mutations</p>
                    </div>
                </div>
                <div class="wgs-item">
                    <div class="wgs-coverage">
                        <span class="coverage-percent">&lt; 1%</span>
                        <span class="coverage-label">of the Genome</span>
                    </div>
                    <div class="wgs-details">
                        <h4>Targeted Panels</h4>
                        <p>~1-2 Million bp</p>
                        <p>Limited mutation detection</p>
                    </div>
                </div>
            </div>
            <div class="clinical-benefit">
                <h4>CLINICAL BENEFIT</h4>
                <div class="benefit-stat">
                    <span class="stat-number">24%</span>
                    <span class="stat-label">Proven Clinical Utility in Pediatric Cancers (Nature Medicine, 2024)</span>
                </div>
            </div>
        </div>
        <div class="advantages-grid">
            <div class="card reveal">
                <h4>Strategic Advantages for Pakistan</h4>
                <div class="advantage-item">
                    <span class="advantage-icon">üéØ</span>
                    <div>
                        <h5>Actionable Mutations</h5>
                        <p>Identifies rare driver mutations linked to approved targeted therapies often missed by panels.</p>
                    </div>
                </div>
                <div class="advantage-item">
                    <span class="advantage-icon">üõ°Ô∏è</span>
                    <div>
                        <h5>Resistance Mechanisms</h5>
                        <p>Detects secondary mutations (e.g., EGFR T790M) to guide second-line therapy choices.</p>
                    </div>
                </div>
                <div class="advantage-item">
                    <span class="advantage-icon">üë®‚Äçüë©‚Äçüëß‚Äçüë¶</span>
                    <div>
                        <h5>Hereditary Risk</h5>
                        <p>Simultaneous analysis of germline DNA to identify familial cancer syndromes for prevention.</p>
                    </div>
                </div>
                <div class="advantage-item">
                    <span class="advantage-icon">üî¨</span>
                    <div>
                        <h5>Clinical Trial Access</h5>
                        <p>Matches patients to global clinical trials based on comprehensive molecular profiling.</p>
                    </div>
                </div>
            </div>
        </div>
        <div class="quote-card reveal">
            <blockquote>
                "Panel testing is like looking through a keyhole; WGS opens the entire door, ensuring no therapeutic opportunity is missed for Pakistani patients."
            </blockquote>
            <p><em>Sources: Nature Medicine (2024); ASCO Precision Oncology (2025); eCancer (2024)</em></p>
        </div>
    </div>
</section>
<section id="expected-outcomes">
    <div class="container">
        <div class="section-title reveal"><h2>Expected Outcomes & Impact</h2>
            <p>Project ROI - Multi-Dimensional Value</p></div>
        <div class="card reveal">
            <h3>TRANSFORMING HEALTHCARE DELIVERY & ECONOMY</h3>
            <p>The establishment of the Center and the 150,000+ WGS initiative will deliver measurable benefits across five strategic pillars, positioning Pakistan as a pioneer in the genomic era.</p>
        </div>
        <div class="outcomes-grid">
            <div class="outcome-card reveal">
                <div class="outcome-header">
                    <span class="outcome-icon">üè•</span>
                    <h4>PATIENT CARE</h4>
                </div>
                <ul>
                    <li><strong>Higher Survival Rates:</strong> Targeted therapies significantly extend progression-free survival</li>
                    <li><strong>Reduced Toxicity:</strong> Avoiding "carpet-bombing" chemo preserves patient immunity</li>
                    <li><strong>Faster Treatment:</strong> Reduced "trial-and-error" prescribing cycles</li>
                </ul>
            </div>
            <div class="outcome-card reveal">
                <div class="outcome-header">
                    <span class="outcome-icon">üí∞</span>
                    <h4>EFFICIENCY</h4>
                </div>
                <ul>
                    <li><strong>Avoid Futile Care:</strong> Stop paying for expensive drugs that won't work genetically</li>
                    <li><strong>Resource Optimization:</strong> Reduced hospital stays due to fewer adverse events</li>
                    <li><strong>Cost Savings:</strong> Long-term reduction in the national cancer burden</li>
                </ul>
            </div>
            <div class="outcome-card reveal">
                <div class="outcome-header">
                    <span class="outcome-icon">üåç</span>
                    <h4>POPULATION</h4>
                </div>
                <ul>
                    <li><strong>Risk Stratification:</strong> Identify high-risk families via hereditary screening</li>
                    <li><strong>Early Detection:</strong> Implement liquid biopsy screening programs</li>
                    <li><strong>Epidemiology:</strong> Understanding the unique genetic makeup of Pakistani cancer</li>
                </ul>
            </div>
        </div>
        <div class="impact-stats">
            <div class="impact-card reveal">
                <div class="impact-number">3x</div>
                <div class="impact-label">IMPROVEMENT IN RESPONSE RATES</div>
            </div>
            <div class="impact-card reveal">
                <div class="impact-number">150k</div>
                <div class="impact-label">GENOMIC PROFILES GENERATED</div>
            </div>
            <div class="impact-card reveal">
                <div class="impact-number">30%-40%</div>
                <div class="impact-label">REDUCTION IN INEFFECTIVE SPEND</div>
            </div>
            <div class="impact-card reveal">
                <div class="impact-number">100+</div>
                <div class="impact-label">PROFESSIONALS TRAINED</div>
            </div>
        </div>
        <div class="vision-section">
            <div class="card reveal">
                <h4>National Strategic Goal</h4>
                <div class="vision-items">
                    <div class="vision-item">
                        <span class="vision-icon">üèÜ</span>
                        <div>
                            <h5>Tier-1 Research Institute Status</h5>
                            <p>Capacity Building: Workforce Development, Research Output, Global Collaboration</p>
                        </div>
                    </div>
                    <div class="vision-item">
                        <span class="vision-icon">üåü</span>
                        <div>
                            <h5>Regional Leadership</h5>
                            <p>First large-scale precision oncology hub in South Asia, Medical Tourism, Sovereignty</p>
                        </div>
                    </div>
                    <div class="vision-item">
                        <span class="vision-icon">üéØ</span>
                        <div>
                            <h5>VISION 2030</h5>
                            <p>In Precision Medicine & Genomics - Regional Leader</p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </div>
</section>
<section id="local-manufacturing" class="hero">
    <div class="container">
        <div class="section-title reveal"><h2>Local Medicine Manufacturing Initiative</h2>
            <p>Building National Biopharma Capacity</p></div>
        <div class="card reveal">
            <h3>Targeted Therapy Production</h3>
            <p>Establish GMP-compliant facilities to manufacture precision oncology drugs locally, reducing reliance on expensive imports.</p>
            <div class="manufacturing-overview">
                <div class="manufacturing-stats">
                    <div class="stat-card reveal">
                        <div class="stat-number">GMP</div>
                        <div class="stat-label">COMPLIANT FACILITIES</div>
                    </div>
                    <div class="stat-card reveal">
                        <div class="stat-number">Local</div>
                        <div class="stat-label">PRODUCTION</div>
                    </div>
                </div>
                <div class="value-chain">
                    <h4>LOCAL VALUE CHAIN CREATION</h4>
                    <div class="chain-steps">
                        <div class="chain-step">
                            <h5>Technology Transfer</h5>
                            <p>Collaborate with global biotech leaders to transfer knowledge, proprietary technologies, and manufacturing processes.</p>
                        </div>
                        <div class="chain-step">
                            <h5>Skilled Workforce</h5>
                            <p>Develop local expertise in biopharmaceutical manufacturing and quality control.</p>
                        </div>
                        <div class="chain-step">
                            <h5>Cost Reduction</h5>
                            <p>Significantly reduce treatment costs through local production and supply chain optimization.</p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </div>
</section>
<section id="implementation-timeline">
    <div class="container">
        <div class="section-title reveal"><h2>Implementation Timeline</h2>
            <p>Execution Plan - From Foundation to Scale</p></div>
        <div class="card reveal">
            <h3>10-YEAR STRATEGIC ROADMAP (5 PHASES)</h3>
            <p>Phased Rollout Strategy - Structured approach to ensure infrastructure readiness before scaling genomic operations.</p>
        </div>
        <div class="timeline-phases">
            <div class="phase-card reveal">
                <div class="phase-number">01</div>
                <div class="phase-content">
                    <h4>Foundation & Setup</h4>
                    <p class="phase-duration">3-6 Month</p>
                    <ul>
                        <li>Infrastructure: Site selection, lab design, and renovation</li>
                        <li>Procurement: Ordering sequencers and IT hardware</li>
                        <li>Recruitment: Hiring core team (geneticists, bioinformaticians)</li>
                        <li>SOPs: Finalize clinical workflows and data protocols</li>
                    </ul>
                    <div class="phase-funding">USD 10.0 Million Funds</div>
                </div>
            </div>
            <div class="phase-card reveal">
                <div class="phase-number">02</div>
                <div class="phase-content">
                    <h4>Capacity Building</h4>
                    <p class="phase-duration">3-6 Months</p>
                    <ul>
                        <li>Training: Overseas fellowship programs for key staff</li>
                        <li>Partnerships: Sign MOUs with international genomic centers</li>
                        <li>System Integration: Precision medicine protocols standardized</li>
                    </ul>
                    <div class="phase-funding">Funds: Investment of USD 50 Million</div>
                </div>
            </div>
            <div class="phase-card reveal">
                <div class="phase-number">03</div>
                <div class="phase-content">
                    <h4>Scaling Operations</h4>
                    <p class="phase-duration">1 Year</p>
                    <ul>
                        <li>Clinical Launch: Open Precision Oncology Clinic to public</li>
                        <li>Ramp Up: Scale to 10,000 genomes/year</li>
                        <li>Impact: Early clinical benefits & paper publications</li>
                    </ul>
                    <div class="phase-funding">Funds: Investment of USD 100.0 Million</div>
                </div>
            </div>
            <div class="phase-card reveal">
                <div class="phase-number">04</div>
                <div class="phase-content">
                    <h4>Full Throttle</h4>
                    <p class="phase-duration">2 Year</p>
                    <ul>
                        <li>Milestone: Complete 100,000 WGS target</li>
                        <li>Deep Analytics: AI-driven discovery of novel variants</li>
                        <li>Database: Launch National Cancer Genomic Atlas</li>
                    </ul>
                    <div class="phase-funding">Funds: Investment of USD 40.0 Million</div>
                </div>
            </div>
            <div class="phase-card reveal">
                <div class="phase-number">05</div>
                <div class="phase-content">
                    <h4>Integration & Legacy</h4>
                    <p class="phase-duration">3 Year</p>
                    <ul>
                        <li>Integration: Precision medicine protocols in all public hospitals</li>
                        <li>Sustainability: Transition to self-sustaining revenue model</li>
                    </ul>
                    <div class="phase-goal">Goal: A fully operational, world-class precision oncology ecosystem by 2028</div>
                </div>
            </div>
        </div>
    </div>
</section>

<footer>
    <div class="container"><strong>Precision Omics</strong><br/>Pioneering Precision Medicine in South Asia</div>
</footer>
<script src="assets/site.js"></script>
</body>
</html>
